RNS Number : 6999X
Maruwa Co Ld
27 April 2023
 

Translation

 

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.

 

Summary of Consolidated Financial Results

for the Year Ended March 31, 2023

(Based on Japanese GAAP)





April 27, 2023

Company name:

MARUWA CO., LTD.


Stock exchange listing:

Tokyo, Nagoya

Stock code:

5344

URL  https://www.maruwa-g.com/

Representative:

President and Representative Director

Toshiro Kanbe

Inquiries:

Director

Yukiko Morishita

TEL  0561-51-0841

Scheduled date of ordinary general meeting of shareholders:

June 22, 2023

Scheduled date to file Securities Report:

June 23, 2023

Scheduled date to commence dividend payments:

June 23, 2023

Preparation of supplementary material on financial results:

Yes


Holding of financial results meeting:

Yes

(for institutional investors and analysts)

 


(Amounts less than one million yen are rounded down)

1. Consolidated financial results for the year ended March 31, 2023 (from April 1, 2022 to March 31, 2023)

(1) Consolidated operating results

Percentages indicate year-on-year changes

 


Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent


Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Year ended March 31, 2023

58,804

8.2

20,142

10.6

21,187

10.5

15,020

12.5

Year ended March 31, 2022

54,344

31.1

18,215

77.7

19,182

85.7

13,350

92.5

 


Earnings per share

Diluted earnings per share

Profit attributable to owners of parent/equity

Ordinary profit/total assets

Operating profit/net sales


Yen

Yen

%

%

%

Year ended March 31, 2023

1,217.45

-

17.3

20.8

34.3

Year ended March 31, 2022

1,082.11

-

18.3

22.1

33.5

 

(2) Consolidated financial position


Total assets

Net assets

Equity ratio

Net assets per share


Millions of yen

Millions of yen

%

Yen

As of March 31, 2023

108,031

94,215

87.2

7,636.60

As of March 31, 2022

95,899

79,681

83.1

6,458.45

 

(3) Consolidated cash flows


Cash flows from operating activities

Cash flows from investing activities

Cash flows from financing activities

Cash and cash equivalents at end of period


Millions of yen

Millions of yen

Millions of yen

Millions of yen

Year ended March 31, 2023

15,647

(8,755)

(1,882)

49,585

Year ended March 31, 2022

14,757

(3,522)

(1,132)

44,385

 

2. Cash dividends

 

 

Annual dividends per share

Total cash dividends (Total)

Dividend payout ratio (Consolidated)

Ratio of dividends to net assets (Consolidated)

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Total


Yen

Yen

Yen

Yen

Yen

Millions of yen

%

%

Year ended March 31, 2022

-

34.00

-

36.00

70.00

863

6.5

1.2

Year ended March 31, 2023

-

38.00

-

40.00

78.00

962

6.4

1.1

Year ending March 31, 2024

(Forecast)

-

43.00

-

43.00

86.00


-


 



3. Forecast of consolidated financial results for the year ending March 31, 2024 (from April 1, 2023 to March 31, 2024)


Percentages indicate year-on-year changes

 


Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Earnings per share


Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Six months ending

September 30, 2023

27,100

(8.7)

9,100

(14.3)

-

-

-

-

-

Full year

61,500

4.6

21,000

4.3

-

-

-

-

-

 

4. Notes

(1) Changes in significant subsidiaries during the year ended March 31, 2023

(changes in specified subsidiaries resulting in the change in scope of consolidation):

Yes

 

(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements

Changes in accounting policies due to revisions to accounting standards and other regulations:

No

Changes in accounting policies due to other reasons:

No

Changes in accounting estimates:

No

Restatement of prior period financial statements:

No

 

(3) Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)


As of March 31, 2023

12,372,000

 shares

As of March 31, 2022

12,372,000

 shares

Number of treasury shares at the end of the period


As of March 31, 2023

34,649

 shares

As of March 31, 2022

34,492

 shares

Average number of shares during the period


Year ended March 31, 2023

12,337,413

 shares

Year ended March 31, 2022

12,337,379

 shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated financial statements

Consolidated balance sheets

 

 

(Millions of yen)

 

As of March 31, 2022

As of March 31, 2023

Assets

 

 

Current assets

 

 

Cash and deposits

44,621

49,795

Notes receivable - trade

473

343

Accounts receivable - trade

12,876

10,701

Electronically recorded monetary claims - operating

1,810

1,820

Merchandise and finished goods

1,632

2,267

Work in process

2,648

2,905

Raw materials and supplies

3,706

3,767

Other

2,389

3,043

Allowance for doubtful accounts

(9)

(9)

Total current assets

70,149

74,634

Non-current assets

 

 

Property, plant and equipment

 

 

Buildings and structures, net

10,101

14,075

Machinery, equipment and vehicles, net

5,478

7,446

Land

4,699

4,872

Construction in progress

2,653

3,920

Other, net

590

731

Total property, plant and equipment

23,524

31,046

Intangible assets

 

 

Other

298

284

Total intangible assets

298

284

Investments and other assets

 

 

Investment securities

230

534

Deferred tax assets

637

484

Investment property, net

948

933

Other

111

114

Allowance for doubtful accounts

(0)

(0)

Total investments and other assets

1,927

2,066

Total non-current assets

25,750

33,397

Total assets

95,899

108,031

 


 

 

 

(Millions of yen)

 

As of March 31, 2022

As of March 31, 2023

Liabilities

 

 

Current liabilities

 

 

Notes and accounts payable - trade

3,444

2,975

Electronically recorded obligations - operating

2,419

1,542

Short-term borrowings

100

-

Current portion of long-term borrowings

866

333

Income taxes payable

4,731

2,684

Provision for bonuses

866

914

Provision for bonuses for directors (and other officers)

71

124

Other

2,455

4,334

Total current liabilities

14,953

12,910

Non-current liabilities

 

 

Long-term borrowings

733

400

Deferred tax liabilities

153

141

Other

377

364

Total non-current liabilities

1,264

905

Total liabilities

16,218

13,816

Net assets

 

 

Shareholders' equity

 

 

Share capital

8,646

8,646

Capital surplus

12,017

12,018

Retained earnings

59,274

73,381

Treasury shares

(207)

(209)

Total shareholders' equity

79,732

93,838

Accumulated other comprehensive income

 

 

Valuation difference on available-for-sale securities

104

125

Foreign currency translation adjustment

(155)

251

Total accumulated other comprehensive income

(51)

377

Total net assets

79,681

94,215

Total liabilities and net assets

95,899

108,031

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated statements of income and consolidated statements of comprehensive income

Consolidated statements of income

 

 

(Millions of yen)

 

Fiscal year ended

March 31, 2022

Fiscal year ended

March 31, 2023

Net sales

54,344

58,804

Cost of sales

27,018

28,396

Gross profit

27,326

30,408

Selling, general and administrative expenses

9,110

10,266

Operating profit

18,215

20,142

Non-operating income

 

 

Interest income

58

107

Rental income

95

98

Foreign exchange gains

810

861

Other

66

45

Total non-operating income

1,029

1,112

Non-operating expenses

 

 

Interest expenses

7

5

Rent expenses on real estate for investments

44

48

Other

11

12

Total non-operating expenses

63

66

Ordinary profit

19,182

21,187

Extraordinary income

 

 

Gain on sale of non-current assets

3

0

Gain on sale of investment securities

9

-

Gain on liquidation of subsidiaries

-

3

Subsidy income

481

515

Compensation income

186

-

Total extraordinary income

680

519

Extraordinary losses

 

 

Loss on sale and retirement of non-current assets

16

61

Loss on tax purpose reduction entry of non-current assets

463

481

Loss related to infectious disease

41

-

Other

8

-

Total extraordinary losses

531

542

Profit before income taxes

19,331

21,164

Income taxes - current

6,208

5,977

Income taxes - deferred

(227)

166

Total income taxes

5,980

6,143

Profit

13,350

15,020

Profit attributable to owners of parent

13,350

15,020

 



 

Consolidated statements of comprehensive income

 

 

(Millions of yen)

 

Fiscal year ended

March 31, 2022

Fiscal year ended

March 31, 2023

Profit

13,350

15,020

Other comprehensive income

 

 

Valuation difference on available-for-sale securities

(15)

20

Foreign currency translation adjustment

851

407

Total other comprehensive income

835

428

Comprehensive income

14,186

15,448

Comprehensive income attributable to

 

 

Comprehensive income attributable to owners of parent

14,186

15,448

 

 



 

Consolidated statements of changes in equity

Fiscal year ended March 31, 2022





(Millions of yen)


Shareholders' equity


Share capital

Capital surplus

Retained earnings

Treasury shares

Total shareholders' equity

Balance at beginning of period

8,646

12,005

46,796

(217)

67,231

Cumulative effects of changes in accounting policies



(8)


(8)

Restated balance

8,646

12,005

46,787

(217)

67,222

Changes during period






Dividends of surplus



(863)


(863)

Profit attributable to owners of parent



13,350


13,350

Purchase of treasury shares




(2)

(2)

Disposal of treasury shares


12


12

24

Net changes in items other than shareholders' equity






Total changes during period

-

12

12,486

10

12,509

Balance at end of period

8,646

12,017

59,274

(207)

79,732

 


Accumulated other comprehensive income

Total net assets


Valuation difference on available-for-sale securities

Foreign currency translation adjustment

Total accumulated other comprehensive income

Balance at beginning of period

119

(1,006)

(886)

66,344

Cumulative effects of changes in accounting policies




(8)

Restated balance

119

(1,006)

(886)

66,335

Changes during period





Dividends of surplus




(863)

Profit attributable to owners of parent




13,350

Purchase of treasury shares




(2)

Disposal of treasury shares




24

Net changes in items other than shareholders' equity

(15)

851

835

835

Total changes during period

(15)

851

835

13,345

Balance at end of period

104

(155)

(51)

79,681

 


Fiscal year ended March 31, 2023





(Millions of yen)


Shareholders' equity


Share capital

Capital surplus

Retained earnings

Treasury shares

Total shareholders' equity

Balance at beginning of period

8,646

12,017

59,274

(207)

79,732

Changes during period






Dividends of surplus



(912)


(912)

Profit attributable to owners of parent



15,020


15,020

Purchase of treasury shares




(2)

(2)

Disposal of treasury shares


0


0

1

Net changes in items other than shareholders' equity






Total changes during period

-

0

14,107

(1)

14,106

Balance at end of period

8,646

12,018

73,381

(209)

93,838

 


Accumulated other comprehensive income

Total net assets


Valuation difference on available-for-sale securities

Foreign currency translation adjustment

Total accumulated other comprehensive income

Balance at beginning of period

104

(155)

(51)

79,681

Changes during period





Dividends of surplus




(912)

Profit attributable to owners of parent




15,020

Purchase of treasury shares




(2)

Disposal of treasury shares




1

Net changes in items other than shareholders' equity

20

407

428

428

Total changes during period

20

407

428

14,534

Balance at end of period

125

251

377

94,215

 

 



 

Consolidated statements of cash flows

 

 

(Millions of yen)

 

Fiscal year ended

March 31, 2022

Fiscal year ended

March 31, 2023

Cash flows from operating activities

 

 

Profit before income taxes

19,331

21,164

Depreciation

2,570

3,087

Increase (decrease) in allowance for doubtful accounts

(34)

(0)

Loss (gain) on sale of investment securities

(0)

-

Loss (gain) on sale and retirement of non-current assets

13

61

Loss on tax purpose reduction entry of non-current assets

463

481

Interest and dividend income

(63)

(112)

Interest expenses

7

5

Subsidy income

(481)

(515)

Compensation income

(186)

-

Decrease (increase) in trade receivables

(3,883)

2,388

Decrease (increase) in inventories

(1,527)

(917)

Increase (decrease) in trade payables

1,519

(1,324)

Other, net

277

(1,007)

Subtotal

18,005

23,310

Interest and dividends received

63

112

Interest paid

(7)

(5)

Income taxes refund (paid)

(3,489)

(7,769)

Proceeds from compensation

186

-

Net cash provided by (used in) operating activities

14,757

15,647

Cash flows from investing activities

 

 

Net decrease (increase) in time deposits

(12)

31

Purchase of property, plant and equipment

(3,738)

(8,697)

Proceeds from sale of property, plant and equipment

6

0

Purchase of intangible assets

(70)

(27)

Purchase of investment securities

(235)

(286)

Proceeds from sale of investment securities

232

-

Subsidies received

285

211

Other, net

9

12

Net cash provided by (used in) investing activities

(3,522)

(8,755)

Cash flows from financing activities

 

 

Repayments of short-term borrowings

-

(100)

Repayments of long-term borrowings

(266)

(866)

Purchase of treasury shares

(2)

(2)

Dividends paid

(863)

(912)

Net cash provided by (used in) financing activities

(1,132)

(1,882)

Effect of exchange rate change on cash and cash equivalents

394

188

Net increase (decrease) in cash and cash equivalents

10,497

5,199

Cash and cash equivalents at beginning of period

33,888

44,385

Cash and cash equivalents at end of period

44,385

49,585

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR VDLBLXZLEBBB